A Phase I Clinical Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of GB221 Injection and Trastuzumab (Herceptin ® ) in Healthy Chinese Adults.
Yu ZhuChen LiLiming ChenHaiyan LiuLun OuTong LiXuan WangTenghua WangJingyuan TianXintong LiangZhiqin HuYaoxuan ZhanShuangshuang XiaoXiaole WangYongmei LiJin HeQingshan ZhengHaifeng SongXianbo LiYi FangPublished in: European journal of drug metabolism and pharmacokinetics (2024)
GB221 demonstrated similar pharmacokinetics to trastuzumab and comparable safety and immunogenicity in healthy Chinese adults.